Pharmacyclics Inc (NASDAQ:PCYC)

254.51
Delayed Data
As of May 01
 -1.69 / -0.66%
Today’s Change
82.51
Today|||52-Week Range
260.47
+108.17%
Year-to-Date

Today’s Trading

Previous close256.20
Today’s open256.29
Day’s range254.00 - 256.61
Volume1,034,498
Average volume (3 months)1,548,061
Market cap$19.5B
Dividend yield--
Data as of 4:00pm ET, 05/01/2015

Growth & Valuation

Earnings growth (last year)+26.44%
Earnings growth (this year)-48.98%
Earnings growth (next 5 years)+54.50%
Revenue growth (last year)+180.48%
P/E ratio230.9
Price/Sales12.61
Price/Book23.31

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...+3.87+3.45%
INCYIncyte Corp+1.12+1.15%
ZTSZoetis Inc+0.19+0.43%
ENDPEndo International P...+0.98+1.17%
Data as of 4:14pm ET, 05/01/2015

Financials

Last reporting dateMay 1, 2015
EPS forecast (this quarter)$0.14
Annual revenue (last year)$729.7M
Annual profit (last year)$86.1M
Net profit margin11.80%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert W. Duggan
Chief Operating Officer
Mahkam Zanganeh
Corporate headquarters
Sunnyvale, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers